Holen Sie sich die Stockscreener-App
21.68
0.23%
-0.05
Handel nachbörslich:
21.68
Schlusskurs vom Vortag:
$21.73
Offen:
$21.83
24-Stunden-Volumen:
641.47K
Relative Volume:
0.84
Marktkapitalisierung:
$2.68B
Einnahmen:
$2.12B
Nettoeinkommen (Verlust:
$29.73M
KGV:
122.21
EPS:
0.1774
Netto-Cashflow:
$162.20M
1W Leistung:
-6.83%
1M Leistung:
-3.17%
6M Leistung:
-4.87%
1J Leistung:
-7.27%
1-Tages-Spanne:
$21.33
$22.05
1-Wochen-Bereich:
$21.33
$23.43
52-Wochen-Spanne:
$18.77
$26.51
Privia Health Group Inc Stock (PRVA) Company Profile
Firmenname
Privia Health Group Inc
Sektor
Branche
Telefon
571-366-8850
Adresse
950 N. GLEBE RD., SUITE 700, ARLINGTON
Compare PRVA vs VEEV, TEM, BTSG, HQY, WAY
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PRVA
Privia Health Group Inc
|
21.68 | 2.68B | 2.12B | 29.73M | 162.20M | 0.1774 |
|
VEEV
Veeva Systems Inc
|
178.88 | 29.40B | 3.20B | 908.91M | 1.42B | 5.4155 |
|
TEM
Tempus Ai Inc
|
49.98 | 8.94B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
BTSG
Brightspring Health Services Inc
|
38.31 | 7.36B | 12.91B | 104.80M | 394.69M | 0.8769 |
|
HQY
Healthequity Inc
|
77.81 | 6.65B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
24.16 | 4.63B | 1.10B | 112.09M | 283.19M | 0.6096 |
Privia Health Group Inc Stock (PRVA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-09 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Outperform |
| 2025-01-10 | Eingeleitet | Needham | Buy |
| 2024-12-16 | Eingeleitet | Macquarie | Outperform |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-04-22 | Eingeleitet | Citigroup | Buy |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2024-02-26 | Fortgesetzt | Jefferies | Buy |
| 2024-02-22 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-12-06 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-06-13 | Eingeleitet | Evercore ISI | Outperform |
| 2023-04-12 | Eingeleitet | Stephens | Overweight |
| 2023-03-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2023-02-03 | Eingeleitet | Goldman | Buy |
| 2022-12-09 | Eingeleitet | Stifel | Buy |
| 2022-12-08 | Eingeleitet | UBS | Buy |
| 2022-09-07 | Fortgesetzt | Truist | Buy |
| 2022-05-03 | Eingeleitet | BofA Securities | Buy |
| 2022-04-28 | Eingeleitet | BTIG Research | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-03-30 | Eingeleitet | Guggenheim | Buy |
| 2022-02-22 | Hochstufung | Cowen | Market Perform → Outperform |
| 2022-01-03 | Eingeleitet | Jefferies | Buy |
| 2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-05-24 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-05-24 | Eingeleitet | Credit Suisse | Outperform |
| 2021-05-24 | Eingeleitet | JP Morgan | Overweight |
| 2021-05-24 | Eingeleitet | Piper Sandler | Overweight |
| 2021-05-24 | Eingeleitet | Truist | Buy |
| 2021-05-24 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Privia Health Group Inc Aktie (PRVA) Neueste Nachrichten
Mountcastle sells multiple PRVA share blocks (NASDAQ: PRVA) - Stock Titan
Privia Health Group opens hiring for Sales Growth Director in Nashville to expand physician partnerships - Traders Union
Privia Health (PRVA) reports Q4: Everything you need to know ahead of earnings - MSN
Insider Sell: Parth Mehrotra Sells Shares of Privia Health Group Inc (PRVA) - GuruFocus
Privia Health Group (NASDAQ:PRVA) CEO Parth Mehrotra Sells 21,097 Shares - MarketBeat
Mehrotra Parth, Privia Health CEO, sells $479k in PRVA stock - Investing.com UK
Mehrotra Parth, Privia Health CEO, sells $479k in PRVA stock By Investing.com - Investing.com South Africa
Privia Health (PRVA) EVP awarded 28,268 restricted stock units - Stock Titan
Parth Mehrotra sells shares at PRVA (NASDAQ: PRVA) — Form 144 notice - Stock Titan
PRVA (NASDAQ: PRVA) Form 144 for 6,453 Shares from Vesting - Stock Titan
Privia Health (PRVA): Buy, Sell, or Hold Post Q4 Earnings? - Yahoo Finance
PRVA (NASDAQ: PRVA) files Form 144 reporting 21,097-share resale - Stock Titan
Parth Mehrotra Sells 41,999 Shares of Privia Health Group (NASDAQ:PRVA) Stock - MarketBeat
Privia Health Group (NASDAQ:PRVA) EVP Edward Fargis Sells 4,394 Shares - MarketBeat
Privia Health Group (NASDAQ:PRVA) EVP Edward Fargis Sells 4,949 Shares - MarketBeat
Privia Health Group (NASDAQ:PRVA) CFO David Mountcastle Sells 5,829 Shares - MarketBeat
Privia Health Group CEO Sells Over 63,000 Shares - TradingView
Privia Health Group (NASDAQ: PRVA) CEO sells shares to cover RSU taxes - Stock Titan
Tax-related share sale by Privia (PRVA) legal chief after RSU vesting - Stock Titan
Privia (PRVA) CFO in nondiscretionary tax sale of 11,006 shares - Stock Titan
(PRVA) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Insider sale notice: PRVA (NASDAQ: PRVA) files to sell 4,949 vested shares - Stock Titan
Insider sale notice lists recent disposals by PRVA (PRVA) reporting person - Stock Titan
Privia Health Group, Inc. (NASDAQ:PRVA) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Privia Health’s EHR Cancer Screening Gains Put Value Based Story In Focus - Yahoo Finance
Privia Health Group, Inc. $PRVA Shares Purchased by Rhenman & Partners Asset Management AB - MarketBeat
Privia Health Soars 9.98% to Hit Intraday High of $25.16 - Markets Mojo
Director sale notice: PRVA (NASDAQ: PRVA) files to sell 5,177 vested shares - Stock Titan
Is Privia Health Group (PRVA) Priced Attractive After Recent Share Price Swings - simplywall.st
Privia Health Earnings Call Highlights Growth And Cash - The Globe and Mail
PRVA Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Breaking Down Privia Health Gr: 5 Analysts Share Their Views - Benzinga
Citigroup Issues Pessimistic Forecast for Privia Health Group (NASDAQ:PRVA) Stock Price - MarketBeat
Marking National Colorectal Cancer Awareness Month, Privia Health Program Achieves 84% Colorectal Cancer Screening Rate Through Industry Collaboration - marketscreener.com
Marking National Colorectal Cancer Awareness Month, Privia Health Program Achieves 84% Colorectal Cancer Screening Rate Through Industry Collaboration – Company AnnouncementFT.com - Financial Times
Privia Health price target raised to $33 from $31 at Truist - Yahoo Finance
Royce & Associates LP Buys 214,166 Shares of Privia Health Group, Inc. $PRVA - MarketBeat
Matthew Shawn Morris Sells 16,550 Shares of Privia Health Group (NASDAQ:PRVA) Stock - MarketBeat
Matthew Shawn Morris Sells 7,788 Shares of Privia Health Group (NASDAQ:PRVA) Stock - MarketBeat
Privia Health Group (NASDAQ:PRVA) CFO David Mountcastle Sells 7,697 Shares - MarketBeat
Privia Health Group (NASDAQ:PRVA) CFO David Mountcastle Sells 5,361 Shares - MarketBeat
Privia Health Group Insider Sold Shares Worth $326,835, According to a Recent SEC Filing - marketscreener.com
Privia Health (PRVA) director sells 24,338 shares after option exercise - Stock Titan
Privia (NASDAQ: PRVA) CFO sells 13,058 shares via 10b5-1 plan - Stock Titan
PRVA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Privia Health Group (NASDAQ:PRVA) Stock Price Expected to Rise, Truist Financial Analyst Says - MarketBeat
Truist Adjusts Price Target on Privia Health to $33 From $31, Maintains Buy Rating - marketscreener.com
Jefferies Maintains Buy on PRVA Privia Health Group, Inc. Feb 2026 - Meyka
Privia Health Group (PRVA) Is Up 8.0% After Earnings Beat And Higher 2026 Revenue Outlook – Has The Bull Case Changed? - simplywall.st
Privia Health Expands Value Based Care Scale With Evolent ACO Acquisition - Yahoo Finance
Privia Health Group (PRVA) Is Up 8.0% After Raising 2026 Revenue Guidance and Beating Q4 Targets - Yahoo Finance
Finanzdaten der Privia Health Group Inc-Aktie (PRVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.79%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):